枯草芽孢杆菌
胆汁酸
5-羟色胺受体
移植手术
蠕动
受体
肝病学
内科学
G蛋白偶联胆汁酸受体
胃肠病学
生物
内分泌学
药理学
化学
血清素
医学
细菌
遗传学
作者
Zhenhai Chen,Jiangyi Feng,Song Hu,Hua Ye,Shaying Ma,Weijie Fu,Qian Yang,Xin Zhang
标识
DOI:10.1007/s10620-021-07308-4
摘要
BackgroundSlow transit constipation (STC) is caused by intestinal peristalsis dysfunction and is closely associated with disturbance of the intestinal microecological balance. Bacillus subtilis plays a positive role in the treatment of STC, but its mechanism needs to be further explored.AimsThe purpose of the present study was to explore the effects and mechanism of B. subtilis on the pathophysiology of STC.MethodsA STC mouse model was established with compound diphenoxylate, following which B. subtilis was used to treat STC. The effects and possible mechanism of B. subtilis on STC were investigated by assessing intestinal motility, histology of the colon, release of 5-HT in enterochromaffin cells (ECs) and the TGR5/TRPA1 pathway. Moreover, LC-MS targeted metabolomics was used to analyze the regulation of Bacillus subtilis on bile acid metabolisms in STC mice.ResultsBacillus subtilis significantly increased 24 h defecations, fecal moisture and intestinal transport rate of STC mice, improved pathological damage of the colon and showed protective effects on the intestinal tract. The release of 5-HT from ECs and the bile acid receptor TGR5/TRPA1 pathway were significantly increased in STC mice treated with B. subtilis. In addition, the metabolomics results showed that the bile acid contents of STC mice were significantly decreased, and B. subtilis could increase the bile acid composition and content of STC mice.ConclusionBacillus subtilis regulates intestinal peristalsis of STC by promoting the release of 5-HT from ECs through bile acid metabolism and its receptor TGR5 pathway and plays a positive role in the treatment of STC.
科研通智能强力驱动
Strongly Powered by AbleSci AI